메뉴 건너뛰기
British Journal of Dermatology
Volumn 156, Issue 5, 2007, Pages 1055-1056
Type II adult-onset pityriasis rubra pilaris successfully treated with intravenous immunoglobulin [6]
Author keywords

[No Author keywords available]
Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; EMOLLIENT AGENT; ETRETIN; HYDROXYUREA; IMMUNOGLOBULIN; INFLIXIMAB; ISOTRETINOIN; METHOTREXATE; PSORALEN; SALICYLIC ACID;
EID: 34247340560     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.07773.x     Document Type: Letter
Times cited : (12)
References (5)
  • 1
    • 14844295399 scopus 로고    scopus 로고
    • Fumaric acid esters therapy: A new treatment modality in pityriasis rubra pilaris?
    • Coras B, Vogt TH, Ulrich H et al. Fumaric acid esters therapy: a new treatment modality in pityriasis rubra pilaris? Br J Dermatol 2005 152:388 9.
    • (2005) Br J Dermatol , vol.152 , pp. 388-9
    • Coras, B.1    Vogt, T.H.2    Ulrich, H.3
  • 2
    • 33645519419 scopus 로고    scopus 로고
    • Successful treatment of type I adult-onset pityriasis rubra pilaris with infliximab
    • Manoharan S, White S, Gumparthy K. Successful treatment of type I adult-onset pityriasis rubra pilaris with infliximab. Australas J Dermatol 2006 47:124 9.
    • (2006) Australas J Dermatol , vol.47 , pp. 124-9
    • Manoharan, S.1    White, S.2    Gumparthy, K.3
  • 3
    • 2442711565 scopus 로고    scopus 로고
    • Extracorporeal photochemotherapy for the treatment of exanthematic pityriasis rubra pilaris
    • Haenssle HA, Bertsch HP, Emmert S et al. Extracorporeal photochemotherapy for the treatment of exanthematic pityriasis rubra pilaris. Clin Exp Dermatol 2004 29:244 6.
    • (2004) Clin Exp Dermatol , vol.29 , pp. 244-6
    • Haenssle, H.A.1    Bertsch, H.P.2    Emmert, S.3
  • 4
    • 33644507418 scopus 로고    scopus 로고
    • Use of IGIV in the treatment of atopic dermatitis, urticaria, scleromyxedema, pyoderma gangrenosum, psoriasis, and pretibial myxedema
    • Jolles S, Hughes J. Use of IGIV in the treatment of atopic dermatitis, urticaria, scleromyxedema, pyoderma gangrenosum, psoriasis, and pretibial myxedema. Int Immunopharmacol 2006 6:579 91.
    • (2006) Int Immunopharmacol , vol.6 , pp. 579-91
    • Jolles, S.1    Hughes, J.2
  • 5
    • 0031933548 scopus 로고    scopus 로고
    • Dermatological uses of high-dose intravenous immunoglobulin
    • Jolles S, Hughes J, Whittaker S. Dermatological uses of high-dose intravenous immunoglobulin. Arch Dermatol 1998 134:80 6.
    • (1998) Arch Dermatol , vol.134 , pp. 80-6
    • Jolles, S.1    Hughes, J.2    Whittaker, S.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.